Electronic Cigarettes and Reactivity to Smoking Cues

Description

The purpose of this study is to determine whether electronic cigarettes can reduce reactivity to smoking-related cues.

Conditions

Nicotine Dependence

Study Overview

Study Details

Study overview

The purpose of this study is to determine whether electronic cigarettes can reduce reactivity to smoking-related cues.

Electronic Cigarettes and Reactivity to Smoking Cues

Electronic Cigarettes and Reactivity to Smoking Cues

Condition
Nicotine Dependence
Intervention / Treatment

-

Contacts and Locations

Belmont

Mclean Hospital Imaging Center, Belmont, Massachusetts, United States, 02478

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Provide written informed consent.
  • 2. Be aged 18-45.
  • 3. Report smoking cigarettes daily in the past 6 months.
  • 4. Have expired breath CO indicative of regular smoking.
  • 5. Have a score greater than 0 on the FTND.
  • 6. Be willing to use Nicotine Replacement Therapy (NRT) and the e-cigarette for a period of 2 to 3 weeks.
  • 7. Speak and read English.
  • 8. Pass an MRI safety screen and meet inclusion criteria for MRI scans.
  • 1. Be pregnant (measured via urinalysis).
  • 2. Meet current abuse or dependence criteria for any substance other than nicotine or caffeine (measured via the SCID 5).
  • 3. Produce a positive urine screen for drugs of abuse or alcohol at the fMRI scan visits.
  • 4. Meet DSM-IV criteria for major depressive episode in the past six months, lifetime DSM-IV diagnosis of organic mental disorder, schizophrenia, schizoaffective disorder, bipolar disorder, delusional disorder or psychotic disorders not elsewhere classified (measured via the SCID 5).
  • 5. Be currently suicidal as assessed by DSM 5 and the Beck Depression Inventory.
  • 6. Current use of medications or any history of a medical condition that might affect the central nervous system at the time of scanning including: Abnormal structural MRI, or a history of head trauma or injury causing loss of consciousness lasting longer than 3 minutes or associated with skull fracture or intracranial bleeding or who had irremovable magnetically active objects on or within their body, history of epilepsy, current use of a beta-blocker or prescription analgesic/anxiolytic. (assessed by self-report).
  • 7. MRI exclusion criteria. (additional information outlined in the "protection of human subjects" section).
  • 8. History of claustrophobia.
  • 9. History of propylene glycol sensitivity/allergy.

Ages Eligible for Study

18 Years to 45 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Mclean Hospital,

Amy C Janes, PhD, PRINCIPAL_INVESTIGATOR, Mclean Hospital

Study Record Dates

2024-10-01